Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Codexis Appoints Vice President of Sales and Marketing

Published: Thursday, June 06, 2013
Last Updated: Thursday, June 06, 2013
Bookmark and Share
Appointment of Scott Watson as Vice President.

Codexis, Inc. has announced the appointment of Scott Watson as Vice President of Sales and Marketing, effective May 2013.

Mr. Watson has more than 25 years of experience in sales, marketing and business development, including in the pharmaceutical and fine chemicals markets.

“Scott brings a strong track record of success to Codexis, along with a wealth of knowledge and connections from his various roles in the pharmaceutical and fine chemical industries,” said John Nicols, President and CEO of Codexis.

Nicols continued, “We continue to expand our pharmaceutical business through new collaborations with strategic partners, and this hire will allow us to capitalize on the many opportunities within both the pharmaceutical industry and other complex chemistry markets where our tailored enzymes can provide significant benefits for our customers.”

“Codexis is the world leader in developing biocatalysts for the pharmaceutical industry and I am very excited to be joining the team at this time,” said Scott Watson.

Watson continued, “The opportunities in the pharmaceutical market continue to grow, and I look forward to helping Codexis further expand its presence, in pharmaceutical and other complex chemistry markets, during the coming years.”

Before joining Codexis, Mr. Watson served most recently as the Executive Director of Sales and Marketing at AMPAC Fine Chemicals, a leading manufacturer of custom small molecule active pharmaceutical ingredients.

From 2008 to 2009, Mr. Watson served as Vice President of Sales and Marketing for Girindus, a diverse service company to the pharmaceutical industry, where he was responsible for realigning the company’s sales strategy.

Prior to Girindus, Mr. Watson held sales positions of growing responsibility with various companies, including Aptuit, DSM and Eastman Chemical Company.

Mr. Watson is a former officer in the U.S. Navy and holds a B.S. in Chemistry from the U.S. Naval Academy and an M.B.A. in Finance and Marketing from George Mason University.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Codexis Signs Multi-year Extension of Contract with Merck
Agreement extension to supply enzyme used in manufacture of sitagliptin.
Tuesday, December 29, 2015
Codexis Announces CodeEvolver Technology License Agreement with Merck
Codexis to receive $5 million in upfront payment.
Friday, August 07, 2015
Codexis Sign Technology License Agreement with GSK
Codexis to receive up to $25M of initial payments, plus additional milestone and royalty opportunities.
Wednesday, July 16, 2014
Codexis Sells its Hungarian Operations
The Hungarian subsidiary is sold for $1.5 million to Intrexon Corporation.
Friday, March 14, 2014
Codexis Appoints Patrick Yang to Board of Directors
Dr. Yang brings significant experience in pharmaceutical manufacturing and process development.
Friday, February 28, 2014
Purolite and Codexis Announce Collaboration
Purolite Corporation and Codexis, Inc. announced a joint collaboration to develop and market immobilized enzymes for the pharmaceutical industry.
Thursday, July 18, 2013
Successful Scale-Up in the Production of CodeXol® Detergent Alcohols
Codexis and Chemtex achieve key milestone in commercial development of bio-based chemicals from non-food cellulosic biomass.
Tuesday, June 18, 2013
Codexis Selected for Third Presidential Green Chemistry Award in Seven Years
The award, from the U.S. Environmental Protection Agency, is for the development of an efficient biocatalytic process to manufacture simvastatin, a leading drug for treating high cholesterol.
Tuesday, June 19, 2012
USPTO Grants Codexis Patent for Enzymes Used in Hep-C Therapeutics
Highlights how Codexis platform enables breakthrough biocatalytic processes.
Friday, May 18, 2012
Nature Highlights Advancements in Biocatalysis
Highlights potential impact on the production of biofuels, renewable chemicals, and pharmaceuticals.
Friday, May 11, 2012
Codexis Awarded Biofuels Enzyme Patent
Patent is cornerstone for company’s cellulosic biofuels program.
Wednesday, March 28, 2012
Codexis Names Wes Bolsen VP and Chief Marketing Officer
Mr Bolsen will have responsibility for the company's corporate marketing and communications.
Tuesday, December 06, 2011
Veteran Chemical Executive to Lead Codexis do Brasil
Achilles Antonio Clement has been named Director, Latin America with responsibility for managing Codexis' expanding role in Latin America.
Thursday, October 13, 2011
Codexis Licenses new Drug Metabolite Profiling and Lead Diversification Technology from Caltech
Codexis will incorporate the licensed technology in development of new R&D productivity tools for use by the pharmaceutical industry.
Thursday, August 30, 2007
Scientific News
Point of Care Diagnostics - A Cautious Revolution
Advances in molecular biology, coupled with the miniaturization and improved sensitivity of assays and devices in general, have enabled a new wave of point-of-care (POC) or “bedside” diagnostics.
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Insight into Eye Diseases
Scientists recreate zebrafish cell regeneration from retinal stem cells in mice.
New Discovery May Benefit Farmers Worldwide
Scientists have shown how a crop-microbe 'team' protect against fungal infection.
Antibodies Paving the Way to HIV Vaccine
Researchers uncover factors responsible for the formation of broadly neutralizing HIV antibodies in humans.
Designing Drugs with a Whole New Toolbox
Researchers develop methods to design small, targeted proteins with shapes not found in nature.
Protein Studies Discover Molecular Secrets
Two protein studies have mapped proteins that reveal the secrets to recycling carbon and healing cells.
Tapping Evolution to Improve Biotech Products
Researchers show how 'ancestral sequence reconstruction' can be used to guide engineering of a blood clotting protein.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!